Skip to Main Content

Paper Details

LDL-cholesterol and PCSK9 in patients with familial hypercholesterolemia: influence of PCSK9 variants under lipid-lowering therapy.
J Clin Lab Anal
1
2021
APOB variants, CAD, FH, Familial hypercholesterolemia, LDL-C, LDL-cholesterol, LDLR, LDLR variants, PCSK9, PCSK9 variants, autosomal dominant genetic disease, cholesterol, coronary artery disease, familial hypercholesterolemia, low-density lipoprotein (LDL) cholesterol, patients, proprotein convertase subtilisin/kexin type 9, proprotein convertase subtilisin/kexin type 9 (PCSK9) gene, statins
Author NameAffiliation
Naoki SakaneClinical Research Institute, National Hospital Organization Kyoto Medical Center
Kazuo HaraJichi Medical University Saitama Medical Center
  • 1 - 2

Datasets

Release 1.2